China Health Technology Group Holding Company Limited completed the allotment and issue of 58.92 million ordinary shares on 17 June 2026 under its previously announced non-underwritten rights issue. The offer was made on the basis of two rights shares for every one existing share held on the record date, at an issue price of HKD 0.25 per share.
Following the issuance, the company’s outstanding share capital expanded from 102.92 million to 161.84 million shares, representing a dilution of 57.25 % to pre-issue shareholders. No treasury shares were involved, and no shares were repurchased or cancelled during the period.
Management confirmed that the rights issue was duly authorised by the board and executed in compliance with all applicable listing rules and regulatory requirements, with all proceeds received in full.
Comments